✦ LIBER ✦

Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets

✍ Scribed by Sarah Rose; Masahiro Nomoto; E.Amanda Jackson; William R.G. Gibb; Peter Jaehnig; Peter Jenner; C.David Marsden

Book ID: 115888876
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 846 KB
Volume: 230
Category: Article
ISSN: 0014-2999
DOI: 10.1016/0014-2999(93)90800-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyri

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset

✍ Jenner, Peter; Rupniak, Nadia M.J.; Rose, Sarah; Kelly, Eamonn; Kilpatrick, Gavi 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Effects of bifemelane on parkinsonism in

Effects of bifemelane on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset

✍ Nomoto, Masahiro; Irifune, Masahiro; Fukuzaki, Kohichiro; Fukuda, Takeo 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Bladder hyperreflexia induced in marmose

Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

✍ Alberto Albanese; Peter Jenner; C.David Marsden; John D. Stephenson 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Age-dependent effects of 1-methyl-4-phen

Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)

✍ M.F. Jarvis; G.C. Wagner 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 305 KB

An appraisal of the antiparkinsonian act

An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets

✍ Lance Smith; Maria De Salvia; Prof. Peter Jenner; C. David Marsden 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

The D2 dopamine agonist piribedil is not widely used in the treatment of Parkinson's disease because it was thought to be effective mainly on parkinsonian tremor and to produce a high incidence of peripheral side effects, particular nausea. In this study, we used 1-methyl-4-phenyl-1,2,3,6-tetrahydro

Lack of Change in Basal Ganglia Neuropep

Lack of Change in Basal Ganglia Neuropeptide Content Following Subacute 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Treatment of the Common Marmoset

✍ P. Jenner; H. Taquet; A. Mauborgne; J. T. Benoliel; F. Cesselin; S. Rose; F. Jav 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB